the future of car-t therapy in the management of dlbcl
Published 1 year ago • 74 plays • Length 6:54Download video MP4
Download video MP3
Similar videos
-
4:29
improving survival outcomes and optimizing car-t therapy in patients with dlbcl
-
3:43
the future of car-t therapy
-
3:52
updates on the use of car-t therapy for the treatment of dlbcl in the second-line setting
-
1:06
car-t cell therapy: current applications and how to improve treatment strategies in the future
-
2:42
clinical indications for car-t therapy in dlbcl & the possibility of moving car-t into earlier lines
-
2:39
the future of car-t therapy: earlier use, new indications, & improved manufacturing
-
2:10
new algorithm for second-line dlbcl: the role of car-t therapy
-
1:20
limitations of car t-cell therapy for dlbcl
-
4:44
optimizing lymphodepletion chemotherapy in car-t therapy recipients
-
3:10
universal car-t therapy for t-all
-
3:01
how the treatment of dlbcl and fl are changing in the uk
-
3:50
updates in the management of car-t toxicities
-
2:19
investigating the genomic drivers of resistance to cd19 car-t therapy in dlbcl
-
3:12
the role of car t-cell therapy in dlbcl
-
3:05
car-t therapy in r/r dlbcl
-
3:23
real-world outcomes of patients with transformed r/r dlbcl treated with cd19 car-t therapy
-
5:24
treatment strategies for patients with dlbcl who relapse after car-t therapy
-
2:25
the future of car-t for the treatment of lymphoma
-
4:02
the future of car-t and cellular therapy
-
1:59
the importance of assessing response to cd19 car-t therapy in lbcl to confirm disease persistence
-
1:19
the future of car t-cell therapy in b-cell malignancies
-
2:08
the future of car t-cell therapy in lymphoma